No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Clinical benefit seen with ibrutinib for relapsed/refractory multiple mantle cell lymphoma in a real-world population

byKathleen Lau

March 11, 2021

in StudyGraphics

RELATED REPORTS

Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

#VisualAbstract: Circulating tumor DNA levels may predict treatment response in patients with advanced melanoma

RelatedReports

Chronic Disease

Management of Dyspnea With High-Flow Nasal Air or Fan-A Randomized Controlled Crossover Trial

January 9, 2026

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial

December 29, 2025

Shorter overall survival among patients with monoclonal gammopathy of undetermined significance

Chronic Disease

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial

December 24, 2025

Chronic Disease

Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen

December 10, 2025

RTS,SA/S01 anti-malarial vaccine efficacy wanes significantly over time

Screening plus Eave Tubes provides a cost-effective strategy to alleviate burden of malaria in Côte d’Ivoire

Epidemiologic features of the 2018-2019 measles outbreak in New York City

Study details societal costs of a measles outbreak

Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Resuming oral anticoagulant (OAC) therapy after an OAC-related bleed associated with higher rates of bleeding

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result